Results 201 to 210 of about 482,280 (260)

Bandgap‐Engineered PtxTey:Ag2Te Composite Quantum Dots Enable Programmable NIR‐II Imaging and Photothermal‐Immune Synergistic Therapy

Advanced Science, EarlyView.
A bandgap‐engineered PtxTey:Ag2Te quantum dot platform enables tunable NIR‐IIb emission for deep‐tissue imaging and mild photothermal therapy. Conjugation with αPD‐L1 confers dual tumor targeting and real‐time monitoring of PD‐L1 dynamics. Mild photothermal modulation induces immune reprogramming, enhancing checkpoint blockade efficacy and achieving ...
Jing Liu, Rui Xu, Quan Wu, Tian‐Xin Xiao, Lai‐Xi Zhao, Lei Sun, Ya‐Wen Zheng, Liang Dong, Zhi‐Quan Tian, Haibo Wang   +9 more
wiley   +1 more source

Reprogramming Metabolism and Immunity: Nanotechnology's Promise for Hepatocellular Carcinoma Precision Therapy. [PDF]

Int J Nanomedicine
Cheng M, Ni Y, Zhang W, Wu Q.
europepmc   +1 more source

Sugar-induced cell death (SICD) in <i>Saccharomyces cerevisiae</i>: insights into nitrogen-mediated rescue and apoptotic cell death pathways. [PDF]

Microb Cell
Parbhudayal R, Cheng HP.
europepmc   +1 more source

Tumor-immune metabolic tug-of-war: from immune escape to targeting metabolic rewiring in cancer therapy. [PDF]

Front Cell Dev Biol
Foglia B, Nurcis J, Signorini M, Cannito S.   +3 more
europepmc   +1 more source

Cancer metabolism: from the Warburg effect to precision therapy. [PDF]

Front Immunol
Wang C, Wang J, Miao L, Wei L, Liu X, Lu Y, Xiang L, Zhang M.   +7 more
europepmc   +1 more source

SNAT1 (SLC38A1) Is Not the Main Glutamine Transporter in Melanoma, but Controls Metabolism via Glutamine-Dependent Activation of P62 (SQSTM1)/cMYC-Axis. [PDF]

Cancers (Basel)
Lörentz S, Böhme-Schäfer I, König J, Sticht H, Bosserhoff AK.   +4 more
europepmc   +1 more source

Metabolic reprogramming as a driver of immune escape in melanoma: implications for immunotherapy. [PDF]

Front Immunol
Liang H, Han L, Feng X, Zhang L.
europepmc   +1 more source

TCA cycle rewiring underpins histone acetylation sourcing and cell-fate transitions during exit from naive pluripotency.

Cell Stem Cell
Kafkia E, Pladevall-Morera D, Argemi-Muntadas L, Wang G, Noberini R, Casòliba-Melich A, Bagés-Arnal S, Anagho-Mattanovich M, Silvério-Alves R, Gassler J, Bonaldi T, Rabelink TJ, Moritz T, Żylicz JJ.   +13 more
europepmc   +1 more source